Intravenous infusions of CSL112, human plasma-derived apolipoprotein A-I (apoA-I), were associated with numerically lower rates of cardiovascular death and myocardial infarction (MI), according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results